Category:Antineoplastic and immunomodulating drug stubs
Help
Category:Antineoplastic and immunomodulating drug stubs
Jump to navigation
Jump to search
This category is maintained by WikiProject Stub sorting. Please propose new stub templates and categories here before creation. |
This category is for stub articles relating to antineoplastic and immunomodulating drugs (ATC code L). You can help by expanding them. To add an article to this category, use antineoplastic-drug-stub instead of stub . |
Pages in category "Antineoplastic and immunomodulating drug stubs"
The following 200 pages are in this category, out of approximately 402 total. This list may not reflect recent changes (learn more).
- Template:Antineoplastic-drug-stub
0–9
- 3F8
- 90Y-DOTA-biotin
A
- Abetimus
- Abexinostat
- Abiraterone
- Δ4-Abiraterone
- Acefluranol
- Aceglatone
- Acetothiolutamide
- Acivicin
- Aclarubicin
- Acolbifene
- Acridine carboxamide
- Actarit
- Adecatumumab
- Aderbasib
- ADH-1
- Adozelesin
- Afelimomab
- Alacizumab pegol
- Alazopeptin
- Albinterferon
- Alestramustine
- Alvocidib
- AMG319
- Amikhelline
- Amonafide
- Amphinex
- Amrubicin
- Amsacrine
- Anatumomab mafenatox
- Ancestim
- Andarine
- Annamycin
- Anti-CD3 monoclonal antibody
- Anti-CD19 immunotoxin
- Anticarcinogen
- Antileukemic drug
- Antiprogestogen
- Apolizumab
- Arctigenin
- Aselizumab
- Asoprisnil
- Atamestane
- Atorolimumab
- Atrimustine
- Axicabtagene ciloleucel
- Azoximer bromide
B
- Batimastat
- Bectumomab
- Belatacept
- Belinostat
- Belotecan
- Bermekimab
- Bertilimumab
- Besilesomab
- 5N-Bicalutamide
- Bifluranol
- Biricodar
- Bivatuzumab mertansine
- BMS-641988
- BMS-906024
- Briakinumab
- Brodalumab
- Bropirimine
C
- Cabazitaxel
- Canakinumab
- Cantuzumab mertansine
- Carboquone
- Carlumab
- Carubicin
- Cedelizumab
- Cemiplimab
- Cepharanthine
- Chemically linked Fab
- Chemoprotective agent
- Chemosensitizer
- Chlorozotocin
- Citatuzumab bogatox
- Cixutumumab
- Clenoliximab
- Combretastatin A-4 phosphate
- Conatumumab
- Cortifen
- Cytestrol acetate
D
- Dabrafenib
- Dacetuzumab
- Dacomitinib
- Dactolisib
- Dalotuzumab
- DAM (chemotherapy)
- Damnacanthal
- Darusentan
- Decernotinib
- Denileukin diftitox
- N-Desmethylapalutamide
- N-Desmethylenzalutamide
- Detumomab
- DHA-paclitaxel
- Dihydrofolate reductase inhibitor
- Dimestrol
- Drozitumab
- Durvalumab
- Dusigitumab
E
- Ecromeximab
- Edrecolomab
- Efalizumab
- Efaproxiral
- Elacestrant
- Elesclomol
- Elotuzumab
- Elsamitrucin
- Elsilimomab
- EM-5854
- Enavatuzumab
- Endoxifen
- Enocitabine
- Enokizumab
- Ensituximab
- Entinostat
- Epoxomicin
- Epratuzumab
- Erbulozole
- Ertumaxomab
- Estradiol mustard
- Estramustine
- Estromustine
- Etalocib
- Etanidazole
- Etaracizumab
- Ethynylandrostanediol
- Etoglucid
- Etrolizumab
- Exatecan
- Exisulind
F
- Fadrozole
- Faralimomab
- Farletuzumab
- Fezakinumab
- Ficlatuzumab
- Figitumumab
- Flanvotumab
- Fluoromedroxyprogesterone acetate
- Fontolizumab
- Foralumab
- Formestane
- Fosfestrol
- Fotemustine
- Fresolimumab
G
- Galiximab
- Ganitumab
- Gavilimomab
- Gevokizumab
- Girentuximab
- Glesatinib
- Glufosfamide
- Gp100:209-217(210M)
H
- 4-Hydroxycyclophosphamide
- Hydroxyflutamide
- 4'-Hydroxynorendoxifen
- Hypomethylating agent
I
- ICI-85966
- ICI-164384
- Icrucumab
- Idarubicin
- Idoxifene
- IFL (chemotherapy)
- Iguratimod
- Illudin
- IMAB362
- Imexon
- Indatuximab ravtansine
- Indium (111In) altumomab pentetate
- Indium (111In) capromab pendetide
- Indium (111In) igovomab
- Indium (111In) satumomab pendetide
- Indusatumab vedotin
- Inolimomab
- Interferon alfa
- Interferon alfa-2b
- Interferon alfacon-1
- Interferon alpha-n3
- Intetumumab
- Iratumumab
- Irosustat
- Isatuximab
- Isoliquiritigenin
- Itolizumab
K
- Keliximab
L
- Labetuzumab
- Laquinimod
- Larotaxel
- Lemalesomab
- Lenograstim
- Lerdelimumab
- Lexatumumab
- Lilotomab
- Linifanib
- Linsitinib
Categories:
- Antineoplastic and immunomodulating drugs
- Stub categories
- Pharmacology stubs
- Oncology stubs
(window.RLQ=window.RLQ||).push(function()mw.config.set("wgPageParseReport":"limitreport":"cputime":"0.056","walltime":"0.103","ppvisitednodes":"value":190,"limit":1000000,"ppgeneratednodes":"value":0,"limit":1500000,"postexpandincludesize":"value":4947,"limit":2097152,"templateargumentsize":"value":268,"limit":2097152,"expansiondepth":"value":7,"limit":40,"expensivefunctioncount":"value":1,"limit":500,"unstrip-depth":"value":0,"limit":20,"unstrip-size":"value":8,"limit":5000000,"entityaccesscount":"value":0,"limit":400,"timingprofile":["100.00% 89.473 1 -total"," 43.55% 38.962 2 Template:Cmbox"," 41.67% 37.282 1 Template:Stub_Category"," 39.01% 34.905 1 Template:WPSS-cat"," 24.37% 21.806 1 Template:Category_handler"," 19.12% 17.106 1 Template:See_also"," 5.61% 5.016 2 Template:Tlx"],"scribunto":"limitreport-timeusage":"value":"0.025","limit":"10.000","limitreport-memusage":"value":973329,"limit":52428800,"cachereport":"origin":"mw1275","timestamp":"20181010163103","ttl":1900800,"transientcontent":false);mw.config.set("wgBackendResponseTime":130,"wgHostname":"mw1247"););